Bristol-Myers Squibb company profile

BMY · NYSE · USD

Compare Bristol-Myers Squibb
$61.35Change from previous close: −2.51%Absolute change: −$1.58

Close · November 17, 2026

Company profile

Bristol-Myers Squibb has 32,500 employees and is headquartered in Princeton, United States.

Doctors and patients treated for cancer, blood disorders, immune diseases, heart conditions and neurological illnesses are the core of the business of Bristol-Myers Squibb Company, which discovers, develops, manufactures and sells biopharmaceutical drugs worldwide. Key brands include Opdivo, Eliquis, Revlimid, Breyanzi and Zeposia, with products such as Cobenfy for schizophrenia and Camzyos for obstructive heart disease. Sales reach customers through a broad network of intermediaries and care providers, and the United States accounts for 69.1% of revenue, with 28.7% from other countries and 2.3% from other regions. The company was founded in 1887 and was formerly known as Bristol-Myers Company.

In the fiscal year ended December 2025, revenue reached 48.2 billion dollars, down 0.2% from the prior year, and net income was 7.1 billion dollars. The company employed 32,500 people and is headquartered in Princeton, New Jersey.

Company facts

Industry
Drug Manufacturers - General
Headquarters
Route 206 & Province Line Road, 08543, Princeton
Employees
32,500
Chief executive
Christopher Boerner
Founded
1887
Fiscal year
January - December
Listing
BMY · NYSE
Indices
S&P 500
Currency
USD
ISIN
US1101221083
Website
bms.com

Bristol-Myers Squibb and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Bristol-Myers SquibbBMYUnited States$125.4B32,50032.4%13.6
PfizerPFEUnited States$164.5B75,00029.1%41.2
Gilead SciencesGILDUnited States$211.18B17,00038.2%—
AmgenAMGNUnited States$250.07B31,50034.1%26.8
Merck & Co.MRKUnited States$356.13B73,00035.2%144.5
BiogenBIIBUnited States$37.07B7,50023.5%107.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Bristol-Myers Squibb with its competitors